文献速递慢阻肺间质性肺疾病哮喘

代谢组学在慢性肺疾病中的应用

Metabolomics in chronic lung diseases.
PubMed 文献 · Respirology · 2019-03-25

本文综述了代谢组学在慢性肺疾病(CLD)研究中的应用,聚焦慢阻肺(COPD)、特发性肺纤维化(IPF)和哮喘。通过分析支气管肺泡灌洗液(BALF)和血浆等样本,质谱(MS)研究显示COPD患者存在鞘脂代谢改变,代谢组学有望成为临床工具。

要点

  • 代谢组学可分析BALF和血浆等样本,用于表征病理状态。
  • 质谱研究显示COPD患者存在鞘脂代谢改变。
  • 代谢组学在COPD、IPF和哮喘中有望提供临床生物标志物。

核心结论

  • 代谢组学通过分析BALF和血浆等样本,可表征慢性肺疾病的病理状态并提供未来临床生物标志物。

研究设计与样本

  • 本文为实用性综述,聚焦COPD、IPF和哮喘的代谢组学研究。

主要发现

  • 质谱研究显示COPD患者鞘脂代谢发生改变。

临床怎么用

  • 代谢组学分析BALF和血浆样本有助于表征慢性肺疾病的病理状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lung diseases represent a significant global burden. Their increasing incidence and complexity render a comprehensive, multidisciplinary and personalized approach to each patient, critically important. Most recently, unique biochemical pathways and disease markers have been identified through large-scale metabolomic studies. Metabolomics is the study of metabolic pathways and the measurement of unique biomolecules in a living system. Analysing samples from different compartments such as bronchoalveolar lavage fluid (BALF) and plasma has proven useful for the characterization of a number of pathological conditions and offers promise as a clinical tool. For example, several studies using mass spectrometry (MS) have shown alterations in the sphingolipid metabolism of chronic obstructive pulmonary disease (COPD) sufferers. In this article, we present a practical review of the application of metabolomics to the study of chronic lung diseases (CLD): COPD, idiopathic pulmonary fibrosis (IPF) and asthma. The insights, which the analytical strategies employed in metabolomics, have provided to the dissection of the biochemistry of CLD and future clinical biomarkers are explored.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Nambiar S, Bong How S, Gummer J, et al. Metabolomics in chronic lung diseases. Respirology. 2019. PMID: 30907495. doi:10.1111/resp.13530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。